Therapeutic banner
Therapeutic banner

Cardiovascular (CV)

View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to Cardiovascular diseases.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.

Congresses

Munich-DE-MOBILE

Transthyretin Amyloidosis (ATTR), Cardiovascular (CV)

European Society of Cardiology (ESC) 2026

Glasgow-uk-mobile

Primary Hyperoxaluria Type 1 (PH1), Cardiovascular (CV)

European Renal Association (ERA) 2026

Gdansk-Poland-Mobile
Congress-AHA-thumbnail

Transthyretin Amyloidosis (ATTR), Cardiovascular (CV)

American College of Cardiology (ACC) 2026

Congress-AHA-thumbnail

Transthyretin Amyloidosis (ATTR), Cardiovascular (CV)

American Heart Association (AHA) 2025

Publications

Cardiovascular (CV)

Add-on Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial

Journal of the American Medical Association

Author(s)

Akshay S. Desai, Adam D. Karns, Jolita Badariene

Cardiovascular (CV)

RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial

The Journal of the American Medical Association

Author(s)

George L Bakris, Manish Saxena, Anil Gupta, et al

Cardiovascular (CV)

Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension

New England Journal of Medicine

Author(s)

Akshay Desai, David Webb, Jorg Taubel, et al

Cardiovascular (CV)

Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease

Hypertension

Author(s)

Dominique Bovée, Liwei Ren, Estrellita Uijl, et al

Cardiovascular (CV)

No evidence for brain renin-angiotensin system activation during DOCA-salt hypertension

Clinical Science

Author(s)

Estrellita Uijl, Liwei Ren, Katrina Mirabito Colafella, et al

Cardiovascular (CV)

RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models

The Journal of Clinical Investigation

Author(s)

Nadine Haase, Donald Foster, Mark Cunningham, et al